Comments
Loading...

Infusion Brands Analyst Ratings

INBIOTCEM
Logo brought to you by Benzinga Data
$0.000001
At close: Apr 28, 10:13 AM EDT

Infusion Brands Analyst Ratings and Price Targets | OTC:INBI | Benzinga

Infusion Brands Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Infusion Brands Corp from these most-recent analyst ratings.

Analyst Ratings for Infusion Brands

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Infusion Brands (INBI) stock?

A

There is no price target for Infusion Brands

Q

What is the most recent analyst rating for Infusion Brands (INBI)?

A

There is no analyst for Infusion Brands

Q

When was the last upgrade for Infusion Brands (INBI)?

A

There is no last upgrade for Infusion Brands

Q

When was the last downgrade for Infusion Brands (INBI)?

A

There is no last downgrade for Infusion Brands.

Q

When is the next analyst rating going to be posted or updated for Infusion Brands (INBI)?

A

There is no next analyst rating for Infusion Brands.

Q

Is the Analyst Rating Infusion Brands (INBI) correct?

A

There is no next analyst rating for Infusion Brands.

Browse analyst ratings and price targets on all stocks.